Pseudomonas aeruginosa, a hospital-acquired bacterium that causes serious infections, can move from the lungs to the gut inside the same patient, raising the risk of sepsis, new research reveals.
A team of researchers comprehensively catalogued a new collection of bacteria-eating viruses called phages. These phages could be used to combat Klebsiella pneumoniae - a serious threat in hospitals.
Researchers have discovered a previously unknown mechanism that explains how bacteria within a tumor can drive treatment resistance in patients with oral and colorectal cancer.
Scientists developed an AI-based approach to diagnose colorectal cancer from different microbial subgroups in the gut microbiota – a non-invasive and low-cost alternative to colonoscopy screening.
The vaginal microbiome is a largely overlooked area of medicine that could dramatically improve outcomes for common infections, infertility and even cancer for millions of women, a new review finds.
Antibiotics are known for disrupting the microbiome in the gut and thus paving the way for diseases. However, many common non-antibiotics also have this effect, a new study shows.
Microbiota composition can help prevent pathogenic bacteria from proliferating, known as the barrier effect. Now, scientists have identified seven bacteria involved, paving the way for new therapies.
A University of Liverpool study has used advanced genetic and genomic techniques to offer a major step forward in understanding and diagnosing infectious intestinal diseases.
Finding ways to target antibiotic-resistant bacteria is a scientific and medical priority. A consortium of researchers identified a compound capable of blocking a key protein for virulence, thus “disarming” the pathogenic bacteria.
In a new study, researchers show that the emergence of antibiotic resistance can be understood in the mechanism of how bacteria build up defences against being infected by viruses.
The gastrointestinal microbiome holds valuable information that can help predict whether immunotherapy will be successful against melanoma. A new “gut-on-a-chip” is designed to do exactly that.
Microbiologists have just shown that people with diabetes are more likely to develop antibiotic-resistant strains of Staphylococcus aureus, a leading cause of AMR-associated infections and deaths.
Researchers explore the connection between the gut and the brain and its impact on the onset of psychiatric and neurological disorders, including Alzheimer’s.
Two recent studies find that resistance can develop against new antibiotics even before they are widely used, compromising their effectiveness from the start.
Two studies indicate warning signs about spread of bacteria resistant to the same group of antibiotics (carbapenems) in both healthcare and community settings across Europe.
New research has shown that using artificial intelligence (AI) can improve how urinary tract infections (UTIs) are treated, and help to address antimicrobial resistance (AMR).
In the laboratory, researchers increased the bactericidal effect of antibiotics 64-fold with the use of a new hydrogel. The material made the antibiotics effective even against resistant bacteria.
It would seem that developing antibiotic resistance would give bacteria an immense advantage over their non-resistant counterparts. So, why do they not become dominant? New research may provide an answer.
Wastewater treatment fails to kill several human pathogens, such as Listeria or E. coli, when they hide out on microplastics in the water, according to a new study.
The gut microbiome varies from person to person in terms of the bacterial species represented and their colonization density. Segatella copri is the most prominent germ. Researchers at the Helmholtz Centre for Infection Research goal to clarify its health significance.
The microbiome – bacteria in the GI tract – is essential for digesting food and training the immune system. New studies explore how repeated antibiotic use can upset this delicate system.
Infections caused by antibiotic-resistant (AMR) bacteria are a major issue in hospitals. A new technique aims to effectively track all types of relevant microorganisms simultaneously.
Toxoplasma gondii is a parasite with the ability to infect the brain, causing life-threatening diseases. Researchers now want to harness its properties to advance treatment of cognitive disorders.
Klebsiella is among the top three pathogens responsible for hospital-acquired infections (HAIs). Now, researchers discovered why the bacteria thrive in clinical environments.
How do pathogenic bacteria evolve to become epidemic? To find out, researchers examined DNA data from almost 10,000 samples taken from infected individuals, animals, and environments around the world.
